Pierre Fenaux Selected Research

FAM protocol

1/2004

A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Fenaux Research Topics

Disease

164	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2022 - 06/2001
57	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 12/2004
28	Neoplasms (Cancer) 10/2022 - 01/2004
24	Acute Promyelocytic Leukemia 12/2021 - 04/2002
22	Leukemia 01/2022 - 02/2002
17	Thrombocytopenia (Thrombopenia) 01/2021 - 03/2003
16	Anemia 12/2021 - 07/2004
14	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022 - 09/2008
11	Neutropenia 10/2021 - 01/2004
8	Hemorrhage 07/2022 - 03/2003
8	Infections 01/2021 - 12/2004
6	Iron Overload 05/2013 - 12/2004
5	Febrile Neutropenia 10/2021 - 04/2016
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2012 - 06/2001
4	VEXAS syndrome 01/2022 - 11/2021
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 03/2003
4	Disease Progression 01/2018 - 08/2010
4	Refractory Anemia with Excess of Blasts (RAEM) 04/2016 - 04/2010
4	Cytopenia 12/2013 - 04/2010
4	Polycythemia Vera 11/2010 - 06/2006
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2004 - 04/2002
3	Vasculitis (Vasculitides) 10/2020 - 04/2012
3	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 11/2010
3	Lymphoma (Lymphomas) 01/2018 - 09/2002
3	Chromosome 5q Deletion Syndrome 07/2013 - 01/2006
2	Leukopenia 10/2021 - 01/2004
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 03/2008
2	Fatigue 01/2020 - 01/2018
2	Diarrhea 01/2020 - 12/2018
2	Nausea 01/2020 - 01/2020
2	Residual Neoplasm 01/2018 - 10/2002
2	Arthritis (Polyarthritis) 09/2017 - 01/2014
2	Breast Neoplasms (Breast Cancer) 11/2012 - 01/2007

Drug/Important Bio-Agent (IBA)

60	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 12/2005
40	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2006
16	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 01/2004
16	HematinicsIBA 01/2021 - 03/2009
15	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021 - 05/2005
14	Pharmaceutical PreparationsIBA 10/2021 - 04/2005
11	Arsenic Trioxide (Trisenox)FDA Link 12/2021 - 04/2002
10	AnthracyclinesIBA 12/2018 - 06/2006
9	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2004
8	Erythropoietin FDA Link 01/2022 - 07/2004
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2014 - 02/2008
6	luspaterceptIBA 11/2022 - 01/2019
6	IronIBA 01/2020 - 07/2010
6	romiplostim FDA Link 03/2018 - 01/2010
6	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 04/2005
6	Decitabine FDA Link 04/2016 - 12/2005
6	ErbB Receptors (EGF Receptor)IBA 12/2014 - 02/2008
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2017
4	SteroidsIBA 01/2021 - 03/2003
4	Inosine Triphosphate (ITP)IBA 01/2021 - 03/2003
4	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2015 - 01/2004
4	Gefitinib (Iressa)FDA Link 09/2013 - 12/2008
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2008 - 07/2004
3	EnzymesIBA 01/2022 - 12/2017
3	Hemoglobins (Hemoglobin)IBA 11/2021 - 07/2013
3	eltrombopag FDA Link 01/2021 - 03/2017
3	Interleukin-2 (IL2)IBA 01/2021 - 03/2008
3	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 12/2018 - 02/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 12/2013
3	Rituximab (Mabthera)FDA Link 09/2017 - 08/2008
3	MethyltransferasesIBA 06/2017 - 12/2005
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2014 - 12/2004
3	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2011 - 01/2004
3	Farnesyltranstransferase (Farnesyltransferase)IBA 05/2008 - 05/2007
2	RG7388IBA 01/2022 - 05/2020
2	Biological ProductsIBA 11/2021 - 10/2020
2	eprenetapoptIBA 10/2021 - 10/2021
2	InflammasomesIBA 01/2021 - 09/2018
2	guadecitabineIBA 01/2019 - 01/2019
2	Ferritins (Ferritin)IBA 01/2019 - 09/2012
2	ArsenicIBA 12/2018 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 04/2005
2	Vorinostat FDA Link 01/2018 - 01/2014
2	ON 01910IBA 12/2017 - 04/2016
2	tocilizumab (atlizumab)FDA Link 09/2017 - 04/2012
2	Thrombopoietin ReceptorsIBA 03/2017 - 05/2013
2	MDS 004IBA 11/2014 - 03/2013
2	InterferonsIBA 12/2013 - 09/2006
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2013 - 02/2010
2	src-Family KinasesIBA 11/2012 - 09/2011
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2012 - 01/2004
2	Deferasirox FDA Link 09/2012 - 09/2010

Therapy/Procedure

45	Therapeutics 10/2022 - 04/2002
28	Drug Therapy (Chemotherapy) 01/2022 - 06/2001
14	Erythrocyte Transfusion 01/2022 - 12/2004
9	Stem Cell Transplantation 09/2014 - 10/2002
6	Induction Chemotherapy 12/2018 - 06/2007
5	Hematopoietic Stem Cell Transplantation 10/2020 - 12/2005
5	Aftercare (After-Treatment) 01/2020 - 04/2005
4	Chelation Therapy (Therapy, Chelation) 01/2020 - 07/2010
3	Drug Tapering 10/2021 - 05/2008
3	Salvage Therapy 11/2019 - 02/2009
3	Platelet Transfusion (Blood Platelet Transfusions) 03/2018 - 01/2010
3	Radiotherapy 06/2014 - 06/2001
2	Cell Transplantation 01/2022 - 09/2012
2	Precision Medicine 09/2021 - 05/2015
2	Consolidation Chemotherapy 12/2018 - 09/2003